10-Q: National Healthcare Properties Reports Q3 2024 Results, Completes Internalization
Quarterly Report
National Healthcare Properties, Inc. announces its Q3 2024 financial results and the successful completion of its internalization, marking a significant shift in its operational structure.
Summary
- National Healthcare Properties, Inc. reported a net loss attributable to common stockholders of $44.1 million for the three months ended September 30, 2024, compared to a net loss of $19.6 million for the same period in 2023.
- Revenue from tenants increased to $88.9 million from $85.7 million year-over-year.
- The company completed its internalization on September 27, 2024, terminating the advisory agreement with Healthcare Trust Advisors, LLC.
- A reverse stock split of one-for-four was effected on September 30, 2024.
- The company disposed of seven OMFs, one SHOP and one land parcel during the three months ended September 30, 2024 for an aggregate contract sales price of $79.3 million, resulting in a gain on sale of $1.6 million.
- The company issued a Promissory Note in a principal amount of $30.3 million to the Advisor Parent in connection with the Internalization.
- The company had $363.7 million outstanding under its credit facilities as of September 30, 2024, with a weighted average interest rate of 7.91%.
Sentiment
Score: 5
Explanation: The sentiment is neutral. While the company completed its internalization and increased revenue, it also reported a larger net loss and issued a promissory note.
Positives
- Revenue from tenants increased to $88.9 million in Q3 2024 from $85.7 million in Q3 2023.
- The company completed its internalization on September 27, 2024, resulting in the termination of the advisory agreement.
- The company disposed of seven OMFs, one SHOP and one land parcel during the three months ended September 30, 2024 for an aggregate contract sales price of $79.3 million, resulting in a gain on sale of $1.6 million.
Negatives
- Net loss attributable to common stockholders was $44.1 million for Q3 2024, compared to $19.6 million for Q3 2023.
- The company issued a Promissory Note in a principal amount of $30.3 million to the Advisor Parent in connection with the Internalization.
Risks
- Continued high interest rates may adversely impact the terms on which the company may borrow in the future and thus its results of operations.
- The company may be adversely impacted by inflation on the leases with tenants in its OMF segment that do not contain indexed escalation provisions, or those leases which have escalations at rates which do not exceed or approximate current inflation rates.
- There can be no assurance that the signed agreements to dispose of seven OMFs for an aggregate contract sales price of $49.8 million will close on their contemplated terms or at all.
Future Outlook
The company expects to fund its future short-term operating liquidity requirements through a combination of current cash on hand, net cash provided by its operating activities, potential future advances under its Fannie Mae Master Credit Facilities and OMF Warehouse Facility, net cash provided by its property dispositions and potential new financings utilizing certain of its currently unencumbered properties.
Industry Context
The announcement reflects trends in the healthcare REIT sector, including portfolio optimization through strategic dispositions and a focus on operational efficiency, as demonstrated by the internalization.
Comparison to Industry Standards
- Global Medical REIT Inc. (GMRE) and Community Healthcare Trust Incorporated (CHCT) are comparible companies in the healthcare REIT sector.
- GMRE has a similar focus on outpatient medical facilities.
- CHCT has a focus on community-based healthcare facilities.
- The internalization strategy is a move towards greater operational control, similar to some larger REITs that manage their operations internally.
- The reverse stock split is a common strategy for companies seeking to improve their stock price and appeal to a broader range of investors.
Related Party Transactions
- The company issued the Promissory Note in a principal amount of $30.3 million to the Advisor Parent in connection with the Internalization.
Stakeholder Impact
- Stockholders will be impacted by the reverse stock split and the change in dividend policy.
- The internalization is expected to improve operational efficiency and reduce related party fees in the long term.
- The company's financial performance may impact its ability to pay dividends on preferred stock.
Next Steps
- The company anticipates primarily using net proceeds from strategic dispositions, which it expects to occur during the fourth quarter of 2024 or the first quarter of 2025, to repay the Promissory Note, which matures on June 28, 2025 and provides for an interest rate step-up to Term SOFR plus 3.25% on and after January 1, 2025.
Key Dates
| Date | Description |
|---|---|
| December 31, 2023 | New Estimated Per-Share NAV published as of this date. |
| March 27, 2024 | Company published a new Estimated Per-Share NAV as of December 31, 2023. |
| September 27, 2024 | Company consummated the Internalization. |
| September 30, 2024 | Reverse stock split of the Company's common stock became effective. |
| September 30, 2024 | Company name changed to National Healthcare Properties, Inc. |
| November 11, 2024 | Date as of which the registrant had 28,296,439 shares of common stock outstanding. |
Keywords
National Healthcare Properties, REIT, Internalization, Financial Results, Healthcare Real Estate, OMF, SHOP, Reverse Stock Split, Promissory Note, Mortgage Notes
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.